Patients with kidney disease are among the most complex, highest-cost patient populations in the U.S. DaVita aims to partner with nephrologists to provide high-quality, patient-centered care for all.
In 2021 and throughout the COVID-19 pandemic, DaVita continued its focus on delivering high-quality care in an equitable way to its patients.
COVID-19 vaccines and boosters were administered to the dialysis community, thanks to state and federal vaccine allocations to the dialysis community.
Home dialysis patients can dialyze from the comfort of home, giving them better control of their treatment schedules, more time for themselves, their families, their jobs and the activities they enjoyed before starting dialysis. DaVita Care Connect® offers another industry-first achievement by incorporating a secure telehealth platform into our home dialysis program.
Hear from DaVita home dialysis patient Terry about how the DaVita Care Connect app helps him get quality care from home.
DaVita patients received convenient home dialysis treatments.*
*Modality selections and decisions related to a patient’s care are always made by the attending nephrologist and patient, and provided pursuant to a physician’s order to a physician’s order. Data as of December 31, 2021..
"At DaVita, we believe an informed patient is an empowered patient. Our data show that patients who participate in Kidney Smart classes are more engaged and better equipped to proactively manage their kidney health at every stage and setting of care."
—Dr. Jeff Giullian,
Chief Medical Officer
people participated in a Kidney Smart® class, a record-setting year of engagement for the no-cost kidney disease education program.
A kidney transplant is an ideal treatment option for many patients with end stage kidney disease (ESKD) to replace kidney function. Our goal is to help everyone eligible pursue a kidney transplant and to inform those who support them.
DaVita patients received a kidney transplant in 2021.
Gaylon is a former professional football player who was determined to get a new kidney. Hear how he found support while dialyzing at DaVita and the moment when he got a very important call.
We strive to support equity at every step of the kidney care journey. Chronic kidney disease (CKD) disproportionately affects communities of color and the disparity continues as patients advance through ESKD, consistent across the industry. We are proud that our patients largely achieve equitable outcomes across key clinical metrics. Our goal is to reduce or eliminate health disparities, including within Home and Transplant. Read more about health equity from Dr. Jeff Giullian, chief medical officer for DaVita Kidney Care, on ModernHealthcare.com.
Integrated Kidney Care
Through DaVita® Integrated Kidney Care (DaVita IKC), patients receive comprehensive care that goes beyond kidney care to cover comorbidities and overall health, from the early stages of CKD to ESKD.
As of December 31, 2021, DaVita IKC provided integrated care and disease management services to approximately 16,000 patients in risk-based integrated care arrangements and to an additional 7,000 patients in other integrated care arrangements.
For more information on our 2021 corporate citizenship initiatives, please visit our ESG Reporting Hub or download our full Community Care ESG Report. Unless otherwise indicated, the data included in this report is as of December 31, 2021 for the Company’s consolidated operations.